ARS Pharmaceuticals (SPRY.BOATS) Q2 2026 Earnings

May 15Confirmed
Q4 2025
Q2 2026
-0.61
-0.56
-0.51
-0.45

Details

Expected EPS
-0.516
Actual EPS
-0.61
Surprise EPS
-0.09
Surprise Percent
-18.22%

Description

⁨ARS Pharmaceuticals⁩ (⁦SPRY.BOATS⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts